SEC Form 4 · accession 0001179022-19-000020
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gilbert F Amelio
Director
Period of report
Jan 21, 2019
Accepted (ET)
Jan 23, 2019 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 21, 2019 | M | 41,500 | $0.89 | A | 161,461 | D | |
| Common Stock | Jan 21, 2019 | F | 7,776 | $4.75 | D | 153,685 | D | |
| Common Stock | Jan 21, 2019 | M | 62,250 | $2.39 | A | 215,935 | D | |
| Common Stock | Jan 21, 2019 | F | 31,322 | $4.75 | D | 184,614 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $0.89 | Jan 21, 2019 | M | 41,500 | D | — | Dec 15, 2026 | Common Stock | 41,500 | 0 | D |
| Stock option (right to buy)F2 | $2.39 | Jan 21, 2019 | M | 62,250 | D | — | Dec 14, 2027 | Common Stock | 62,250 | 0 | D |
Explanation of responses
- F1The options vested 100% on December 14, 2017.
- F2The options vested 100% on December 14, 2018.